Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Private Securities Litigation Reform Act

Private Securities Litigation Reform Act Newsletter

SWKS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Skyworks Solutions, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit 27 Apr 2025 15:00 GMT
… . THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor …
KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma 27 Apr 2025 16:10 GMT
… provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are …
APP INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that AppLovin Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit 27 Apr 2025 16:15 GMT
… . THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor …
Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting 27 Apr 2025 16:05 GMT
… meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in …
New Long-Term Follow-Up Data from OPTIMA II Study of UGN-102 Demonstrates Median Duration of Response of Two Years in Patients with LG-IR-NMIBC 27 Apr 2025 16:43 GMT
… term is defined in the Private Securities Litigation Reform Act of 1995, including, without limitation …
New Patient-Reported Outcomes from UGN-102 Clinical Trials Show the Investigational Treatment Did Not Adversely Affect Functionality, Symptom Burden, and Quality of Life in Patients with LG-IR-NMIBC 27 Apr 2025 17:17 GMT
… term is defined in the Private Securities Litigation Reform Act of 1995, including, without limitation …
SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union 27 Apr 2025 14:35 GMT
… ” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, relating …
UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025 27 Apr 2025 13:00 GMT
… .com. Forward-Looking Statements: The Private Securities Litigation Reform Act of 1995 provides a safe …
Medtronic Affera pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients 27 Apr 2025 04:51 GMT
… provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements …
UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC) 26 Apr 2025 22:44 GMT
… term is defined in the Private Securities Litigation Reform Act of 1995, including, without limitation …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS